Literature DB >> 26292362

ΔNp63α Promotes Breast Cancer Cell Motility through the Selective Activation of Components of the Epithelial-to-Mesenchymal Transition Program.

Tuyen T Dang1, Matthew A Esparza1, Erin A Maine1, Jill M Westcott1, Gray W Pearson2.   

Abstract

Cell identity signals influence the invasive capability of tumor cells, as demonstrated by the selection for programs of epithelial-to-mesenchymal transition (EMT) during malignant progression. Breast cancer cells retain canonical epithelial traits and invade collectively as cohesive groups of cells, but the signaling pathways critical to their invasive capabilities are still incompletely understood. Here we report that the transcription factor ΔNp63α drives the migration of basal-like breast cancer (BLBC) cells by inducing a hybrid mesenchymal/epithelial state. Through a combination of expression analysis and functional testing across multiple BLBC cell populations, we determined that ΔNp63α induces migration by elevating the expression of the EMT program components Slug and Axl. Interestingly, ΔNp63α also increased the expression of miR-205, which can silence ZEB1/2 to prevent the loss of epithelial character caused by EMT induction. In clinical specimens, co-expression of various elements of the ΔNp63α pathway confirmed its implication in motility signaling in BLBC. We observed that activation of the ΔNp63α pathway occurred during the transition from noninvasive ductal carcinoma in situ to invasive breast cancer. Notably, in an orthotopic tumor model, Slug expression was sufficient to induce collective invasion of E-cadherin-expressing BLBC cells. Together, our results illustrate how ΔNp63α can drive breast cancer cell invasion by selectively engaging promigratory components of the EMT program while, in parallel, still promoting the retention of epithelial character. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26292362      PMCID: PMC4573836          DOI: 10.1158/0008-5472.CAN-14-3363

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  50 in total

1.  MicroRNA-based regulation of epithelial-hybrid-mesenchymal fate determination.

Authors:  Mingyang Lu; Mohit Kumar Jolly; Herbert Levine; José N Onuchic; Eshel Ben-Jacob
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-23       Impact factor: 11.205

Review 2.  The epigenetics of epithelial-mesenchymal plasticity in cancer.

Authors:  Wai Leong Tam; Robert A Weinberg
Journal:  Nat Med       Date:  2013-11-07       Impact factor: 53.440

3.  Slug and Sox9 cooperatively determine the mammary stem cell state.

Authors:  Wenjun Guo; Zuzana Keckesova; Joana Liu Donaher; Tsukasa Shibue; Verena Tischler; Ferenc Reinhardt; Shalev Itzkovitz; Aurelia Noske; Ursina Zürrer-Härdi; George Bell; Wai Leong Tam; Sendurai A Mani; Alexander van Oudenaarden; Robert A Weinberg
Journal:  Cell       Date:  2012-03-02       Impact factor: 41.582

4.  Collective invasion in breast cancer requires a conserved basal epithelial program.

Authors:  Kevin J Cheung; Edward Gabrielson; Zena Werb; Andrew J Ewald
Journal:  Cell       Date:  2013-12-12       Impact factor: 41.582

5.  Breast cancer subtype-specific interactions with the microenvironment dictate mechanisms of invasion.

Authors:  Tuyen T Dang; Amanda M Prechtl; Gray W Pearson
Journal:  Cancer Res       Date:  2011-09-09       Impact factor: 12.701

6.  Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes.

Authors:  Joseph H Taube; Jason I Herschkowitz; Kakajan Komurov; Alicia Y Zhou; Supriya Gupta; Jing Yang; Kimberly Hartwell; Tamer T Onder; Piyush B Gupta; Kurt W Evans; Brett G Hollier; Prahlad T Ram; Eric S Lander; Jeffrey M Rosen; Robert A Weinberg; Sendurai A Mani
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-16       Impact factor: 11.205

7.  Signaling between transforming growth factor β (TGF-β) and transcription factor SNAI2 represses expression of microRNA miR-203 to promote epithelial-mesenchymal transition and tumor metastasis.

Authors:  Xiangming Ding; Serk In Park; Laurie K McCauley; Cun-Yu Wang
Journal:  J Biol Chem       Date:  2013-02-27       Impact factor: 5.157

8.  Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition.

Authors:  Min Yu; Aditya Bardia; Ben S Wittner; Shannon L Stott; Malgorzata E Smas; David T Ting; Steven J Isakoff; Jordan C Ciciliano; Marissa N Wells; Ajay M Shah; Kyle F Concannon; Maria C Donaldson; Lecia V Sequist; Elena Brachtel; Dennis Sgroi; Jose Baselga; Sridhar Ramaswamy; Mehmet Toner; Daniel A Haber; Shyamala Maheswaran
Journal:  Science       Date:  2013-02-01       Impact factor: 47.728

9.  EpCAM expression varies significantly and is differentially associated with prognosis in the luminal B HER2(+), basal-like, and HER2 intrinsic subtypes of breast cancer.

Authors:  S D Soysal; S Muenst; T Barbie; T Fleming; F Gao; G Spizzo; D Oertli; C T Viehl; E C Obermann; W E Gillanders
Journal:  Br J Cancer       Date:  2013-03-21       Impact factor: 7.640

10.  MiR203 mediates subversion of stem cell properties during mammary epithelial differentiation via repression of ΔNP63α and promotes mesenchymal-to-epithelial transition.

Authors:  A J DeCastro; K A Dunphy; J Hutchinson; A L Balboni; P Cherukuri; D J Jerry; J DiRenzo
Journal:  Cell Death Dis       Date:  2013-02-28       Impact factor: 8.469

View more
  36 in total

Review 1.  Chronic Obstructive Pulmonary Disease and Lung Cancer: Underlying Pathophysiology and New Therapeutic Modalities.

Authors:  Mathew Suji Eapen; Philip M Hansbro; Anna-Karin Larsson-Callerfelt; Mohit K Jolly; Stephen Myers; Pawan Sharma; Bernadette Jones; Md Atiqur Rahman; James Markos; Collin Chia; Josie Larby; Greg Haug; Ashutosh Hardikar; Heinrich C Weber; George Mabeza; Vinicius Cavalheri; Yet H Khor; Christine F McDonald; Sukhwinder Singh Sohal
Journal:  Drugs       Date:  2018-11       Impact factor: 9.546

Review 2.  Epithelial-mesenchymal transition (EMT): A biological process in the development, stem cell differentiation, and tumorigenesis.

Authors:  Tong Chen; Yanan You; Hua Jiang; Zack Z Wang
Journal:  J Cell Physiol       Date:  2017-04-10       Impact factor: 6.384

3.  Testing the gene expression classification of the EMT spectrum.

Authors:  Dongya Jia; Jason T George; Satyendra C Tripathi; Deepali L Kundnani; Mingyang Lu; Samir M Hanash; José N Onuchic; Mohit Kumar Jolly; Herbert Levine
Journal:  Phys Biol       Date:  2019-01-18       Impact factor: 2.583

4.  ΔNp63α exerts antitumor functions in cervical squamous cell carcinoma.

Authors:  Ying Zhou; Hanyuan Liu; Juan Wang; Xiaolin Wang; Lili Qian; Fei Xu; Weiguo Song; Dabao Wu; Zhen Shen; Dingqing Feng; Bin Ling; Weihua Xiao; Ge Shan; Liang Chen
Journal:  Oncogene       Date:  2019-10-01       Impact factor: 9.867

5.  ΔNp63α attenuates tumor aggressiveness by suppressing miR-205/ZEB1-mediated epithelial-mesenchymal transition in cervical squamous cell carcinoma.

Authors:  Weidong Zhao; Huiyan Wang; Xiaohui Han; Jie Ma; Yuanyuan Zhou; Zhengzheng Chen; Hu Zhou; Hanjie Xu; Zhengwei Sun; Beihua Kong; Huiying Fang
Journal:  Tumour Biol       Date:  2016-02-10

Review 6.  Interconnected high-dimensional landscapes of epithelial-mesenchymal plasticity and stemness in cancer.

Authors:  Sarthak Sahoo; Bazella Ashraf; Atchuta Srinivas Duddu; Adrian Biddle; Mohit Kumar Jolly
Journal:  Clin Exp Metastasis       Date:  2022-01-07       Impact factor: 5.150

7.  Altered expression of p63 isoforms and expansion of p63- and club cell secretory protein-positive epithelial cells in the lung as novel features of aging.

Authors:  Jutaro Fukumoto; Sahebgowda Sidramagowda Patil; Sudarshan Krishnamurthy; Smita Saji; Irene John; Venkata Ramireddy Narala; Helena Hernández-Cuervo; Matthew Alleyn; Mason T Breitzig; Lakshmi Galam; Ramani Soundararajan; Uddhav K Chaudhari; Barbara C Hansen; Richard F Lockey; Narasaiah Kolliputi
Journal:  Am J Physiol Cell Physiol       Date:  2019-01-16       Impact factor: 4.249

8.  ΔNp63 regulates cell proliferation, differentiation, adhesion, and migration in the BL2 subtype of basal-like breast cancer.

Authors:  Paulina Orzol; Marta Nekulova; Jitka Holcakova; Petr Muller; Borivoj Votesek; Philip J Coates
Journal:  Tumour Biol       Date:  2016-01-29

Review 9.  Breast cancer as an example of tumour heterogeneity and tumour cell plasticity during malignant progression.

Authors:  Fabiana Lüönd; Stefanie Tiede; Gerhard Christofori
Journal:  Br J Cancer       Date:  2021-04-06       Impact factor: 7.640

10.  WNK1 Enhances Migration and Invasion in Breast Cancer Models.

Authors:  Ankita B Jaykumar; Ji-Ung Jung; Pravat Kumar Parida; Tuyen T Dang; Chonlarat Wichaidit; Ashari Rashmi Kannangara; Svetlana Earnest; Elizabeth J Goldsmith; Gray W Pearson; Srinivas Malladi; Melanie H Cobb
Journal:  Mol Cancer Ther       Date:  2021-07-12       Impact factor: 6.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.